Research Antibodies Market: By Product, By Type, By Technology, By Source, By Application, By End User and Region Forecast 2020-2031
Research Antibodies Market size was valued at US$ 1.7 billion in 2024 and is expected to reach US$ 2.3 billion by 2031, growing at a significant CAGR of 4.8% from 2025-2031. The global market provides a detailed overview of the market and that can be segmented by product, type, technology, source, application and end user. By product, the market has been segmented into primary and secondary. The primary segment is likely to be the largest and fastest-growing segment in terms of product. Based on type, the market is segmented into monoclonal antibodies and polyclonal antibodies. Among these, the monoclonal antibodies segment is expected to have the fastest-growing market during the forecast period 2023-2029. On the basis of technology, the market is segregated into immunohistochemistry, immunofluorescence, western blotting, flow cytometry, immunoprecipitation, ELISA and other technologies.
The immunohistochemistry segment held considerable market share during the forecast period. Based on source, the market is segregated into mouse, rabbit, goat and other sources. The mouse segment held considerable market share during the forecast period. By application, market is segmented into infectious diseases, immunology, oncology, stem cells, neurobiology and other applications. Infectious diseases segment held substantial market growth during estimated period. On the basis of End User, market is segregated into Academic & Research Institutes, Contract Research Organizations and Pharmaceutical & Biotechnology Companies
Study Period
2025-2031Base Year
2024CAGR
4.8%Largest Market
Asia-PacificFastest Growing Market
North-America
These strong R&D activities for the creation of new vaccination and treatment methods have significantly boosted the need for research antibodies. Additionally, numerous government and private organizations are working very hard to raise money for the creation of COVID-19 vaccines and treatments.
The rise in demand for high-quality antibodies for reproducible research is one of the main factors driving the market. The research antibodies market is expanding as a result of rising proteomics and genomics research fields and expanded life sciences research and development initiatives.
North America market is expected to witness the highest market share during the forecast period due to growing need for optimal crop production, supportive government measures to adopt improved agricultural technology, and players' focusing on new technology and efforts to introduce new criteria have resulted in significant cost savings in farming techniques.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2025-2031 |
|
Market Size in 2024 |
US$ 1.7 billion |
|
Market Size in 2031 |
US$ 2.3 billion |
|
Market CAGR |
4.8% |
|
By Product |
|
|
By Type |
|
|
By Technology |
|
|
By Source |
|
|
By Application |
|
|
By End User |
|
Download Free Sample Report
Research antibodies market size was valued at US$ 1.7 billion in 2024 and is expected to reach US$ 2.3 billion by 2031, growing at a significant CAGR of 4.8%.
North America is the fastest-growing region for the market
The key players of the market are Abcam Plc, Bio-rad Laboratories, Becton Dickinson & Company, Merck, Millipore, Lonza Group.
| 1.Executive Summary |
| 2.Global Research Antibodies Market Introduction |
| 2.1.Global Research Antibodies Market - Taxonomy |
| 2.2.Global Research Antibodies Market - Definitions |
| 2.2.1.Product |
| 2.2.2.Type |
| 2.2.3.Technology |
| 2.2.4.Source |
| 2.2.5.Region |
| 3.Global Research Antibodies Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Research Antibodies Market Analysis, 2020-2024 and Forecast 2025-2031 |
| 4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Research Antibodies Market By Product, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
| 5.1. Primary |
| 5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Secondary |
| 5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6.Global Research Antibodies Market By Type, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
| 6.1. Monoclonal Antibodies |
| 6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Polyclonal Antibodies |
| 6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7.Global Research Antibodies Market By Technology, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
| 7.1. Immunohistochemistry |
| 7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Immunofluorescence |
| 7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Western Blotting |
| 7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Flow Cytometry |
| 7.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Immunoprecipitation |
| 7.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 7.6. ELISA |
| 7.6.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.6.3. Market Opportunity Analysis |
| 7.7. Technologies |
| 7.7.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.7.3. Market Opportunity Analysis |
| 8.Global Research Antibodies Market By Source, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
| 8.1. Mouse |
| 8.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Rabbit |
| 8.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Goat |
| 8.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Sources |
| 8.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 9.Global Research Antibodies Market By Region, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10.North America Research Antibodies Market, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
| 10.1. Product Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Primary |
| 10.1.2.Secondary |
| 10.2. Type Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Monoclonal Antibodies |
| 10.2.2.Polyclonal Antibodies |
| 10.3. Technology Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Immunohistochemistry |
| 10.3.2.Immunofluorescence |
| 10.3.3.Western Blotting |
| 10.3.4.Flow Cytometry |
| 10.3.5.Immunoprecipitation |
| 10.3.6.ELISA |
| 10.3.7.Technologies |
| 10.4. Source Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Mouse |
| 10.4.2.Rabbit |
| 10.4.3.Goat |
| 10.4.4.Sources |
| 10.5. Country Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11.Europe Research Antibodies Market, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
| 11.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Primary |
| 11.1.2.Secondary |
| 11.2. Type Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Monoclonal Antibodies |
| 11.2.2.Polyclonal Antibodies |
| 11.3. Technology Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Immunohistochemistry |
| 11.3.2.Immunofluorescence |
| 11.3.3.Western Blotting |
| 11.3.4.Flow Cytometry |
| 11.3.5.Immunoprecipitation |
| 11.3.6.ELISA |
| 11.3.7.Technologies |
| 11.4. Source Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Mouse |
| 11.4.2.Rabbit |
| 11.4.3.Goat |
| 11.4.4.Sources |
| 11.5. Country Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 11.5.6.Rest of EU |
| 12.Asia Pacific (APAC) Research Antibodies Market, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
| 12.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Primary |
| 12.1.2.Secondary |
| 12.2. Type Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Monoclonal Antibodies |
| 12.2.2.Polyclonal Antibodies |
| 12.3. Technology Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Immunohistochemistry |
| 12.3.2.Immunofluorescence |
| 12.3.3.Western Blotting |
| 12.3.4.Flow Cytometry |
| 12.3.5.Immunoprecipitation |
| 12.3.6.ELISA |
| 12.3.7.Technologies |
| 12.4. Source Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Mouse |
| 12.4.2.Rabbit |
| 12.4.3.Goat |
| 12.4.4.Sources |
| 12.5. Country Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13.Middle East and Africa (MEA) Research Antibodies Market, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
| 13.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Primary |
| 13.1.2.Secondary |
| 13.2. Type Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Monoclonal Antibodies |
| 13.2.2.Polyclonal Antibodies |
| 13.3. Technology Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Immunohistochemistry |
| 13.3.2.Immunofluorescence |
| 13.3.3.Western Blotting |
| 13.3.4.Flow Cytometry |
| 13.3.5.Immunoprecipitation |
| 13.3.6.ELISA |
| 13.3.7.Technologies |
| 13.4. Source Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Mouse |
| 13.4.2.Rabbit |
| 13.4.3.Goat |
| 13.4.4.Sources |
| 13.5. Country Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14.Latin America Research Antibodies Market, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
| 14.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Primary |
| 14.1.2.Secondary |
| 14.2. Type Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Monoclonal Antibodies |
| 14.2.2.Polyclonal Antibodies |
| 14.3. Technology Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Immunohistochemistry |
| 14.3.2.Immunofluorescence |
| 14.3.3.Western Blotting |
| 14.3.4.Flow Cytometry |
| 14.3.5.Immunoprecipitation |
| 14.3.6.ELISA |
| 14.3.7.Technologies |
| 14.4. Source Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Mouse |
| 14.4.2.Rabbit |
| 14.4.3.Goat |
| 14.4.4.Sources |
| 14.5. Country Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Abcam Plc |
| 15.2.2.Bio-rad Laboratories |
| 15.2.3.Becton Dickinson & Company |
| 15.2.4.Merck Millipore |
| 15.2.5.Lonza Group |
| 15.2.6.Thermo Fisher Scientific |
| 15.2.7.Cell Signalling Technology |
| 15.2.8.Hoffmann La Roche |
| 15.2.9.Agilent Technologies |
| 15.2.10.Perkinelmer, Inc. |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Sample
